Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :iii

    
• • ·Information for Readers

    Page :iv

    

• Results of Expert Meetings

  • ·Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System

    Page :113-119

    Toby Rogers, M. Chadi Alraies, Rebecca Torguson, Ron Waksman

    Plan Plan  

• Trial Designs

  • ·Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: Rationale, design, and baseline characteristics

    Page :1-12

    Michelle A. Albert, Eva M. Durazo, Natalie Slopen, Alan M. Zaslavsky, Julie E. Buring, Ted Silva, Daniel Chasman, David R. Williams

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro–B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department

    Page :26-37

    Hanna Kim Gaggin, Annabel Angela Chen-Tournoux, Robert H. Christenson, Gheorghe Doros, Judd Eric Hollander, Phillip David Levy, John Tobias Nagurney, Richard Michael Nowak, Peter S. Pang, Darshita Patel, Willam Frank Peacock, Elizabeth Lea Walters, James Louis Januzzi, on behalf of the ICON-RELOADED Investigators

    Résumé Résumé Plan Plan  
  • ·Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome

    Page :48-56

    Sunjay Kaushal, Brody Wehman, Nicholas Pietris, Casey Naughton, Soren M. Bentzen, Grace Bigham, Rachana Mishra, Sudhish Sharma, Luca Vricella, Allen D. Everett, Kristopher B. Deatrick, Sihong Huang, Helina Mehta, William A. Ravekes, Naru Hibino, Darcy L. Difede, Aisha Khan, Joshua M. Hare

    Résumé Résumé Plan Plan  
  • ·The Lipid-Rich Plaque Study of vulnerable plaques and vulnerable patients: Study design and rationale

    Page :98-104

    Ron Waksman, Rebecca Torguson, Mia-Ashley Spad, Hector Garcia-Garcia, James Ware, Rui Wang, Sean Madden, Priti Shah, James Muller

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease

    Page :13-18

    Ryan Jessee, Erica Peart, Phil Beineke, Steven Rosenberg, James A. Wingrove, William E. Kraus, Kim M. Huffman

    Résumé Résumé Plan Plan   
  • ·Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study

    Page :19-25

    Oluwaseun E. Fashanu, Faye L. Norby, David Aguilar, Christie M. Ballantyne, Ron C. Hoogeveen, Lin Y. Chen, Elsayed Z. Soliman, Alvaro Alonso, Aaron R. Folsom

    Résumé Résumé Plan Plan   
  • ·Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)

    Page :38-47

    Dragos Vinereanu, Hussein R. Al-Khalidi, Meena P. Rao, Wensheng He, Renato D. Lopes, Cecilia M. Bahit, Andrea O. Ciobanu, Kathleen A. Fox, Sean D. Pokorney, Ying Xian, Jie Jiang, Deepak Y. Kamath, Otavio Berwanger, Carlos Tajer, Yong Huo, Denis Xavier, Christopher B. Granger

    Résumé Résumé Plan Plan   
  • ·Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve

    Page :57-63

    Mirjam Keßler, Birgid Gonska, Julia Seeger, Wolfgang Rottbauer, Jochen Wöhrle

    Résumé Résumé Plan Plan  
  • ·Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis

    Page :64-75

    Marco Mojoli, Bernard J. Gersh, Alberto Barioli, Giulia Masiero, Paola Tellaroli, Gianpiero D'Amico, Giuseppe Tarantini

    Résumé Résumé Plan Plan   
  • ·High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3

    Page :76-84

    Ron Waksman, George L. Bakris, Arie Steinvil, Hector Garcia-Garcia, Angela L. Brown, William DiFilippo, Thomas Scott, Jasvindar Singh, Vanessa DeBruin, Denise Jones, Dan Jolivette, Deepak L. Bhatt

    Résumé Résumé Plan Plan  
  • ·Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database

    Page :85-97

    Michael L. O'Byrne, Russell T. Shinohara, Elena K. Grant, Joshua P. Kanter, Matthew J. Gillespie, Yoav Dori, Jonathan J. Rome, Andrew C. Glatz

    Résumé Résumé Plan Plan   
  • ·Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI

    Page :105-112

    Payam Dehghani, Andrea Lavoie, Shahar Lavi, Jennifer J. Crawford, Sebastian Harenberg, Rodney H. Zimmermann, Jeff Booker, Sheila Kelly, Warren J. Cantor, Shamir R. Mehta, Akshay Bagai, Shaun G. Goodman, Asim N. Cheema

    Résumé Résumé Plan Plan   
  • ·Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities

    Page :120-127

    Yochai Adir, Marco Guazzi, Amir Offer, Pier Luigi Temporelli, Antonia Cannito, Stefano Ghio

    Résumé Résumé Plan Plan  

• Letter to the Editors

  • ·Cardiac rehabilitation in heart failure with reduced ejection fraction: A “should take it and not leave it” intervention

    Page :e1

    Rod Taylor, Hayes Dalal, Russell Davies, Patrick Doherty, Kate Jolly, Chim Lang, Jenny Wingham

     
  • ·Building the case for aerobic exercise in ambulatory patients with heart failure and a reduced ejection fraction

    Page :e3

    Lukasz P. Cerbin, Andrew P. Ambrosy, Robert J. Mentz

    
  • ·Response to the letter to the editor

    Page :e5

    Kelsey M. Flint